Ma B - Search Results

Year	Number of Results
1925	1
1962	1
1966	2
1967	1
1969	2
1970	1
1976	2
1978	1
1980	6
1981	2
1982	3
1983	6
1984	3
1986	3
1987	1
1988	2
1989	3
1990	3
1991	3
1992	6
1993	5
1994	3
1995	3
1996	9
1997	12
1998	8
1999	19
2000	26
2001	28
2002	42
2003	51
2004	65
2005	82
2006	101
2007	112
2008	114
2009	130
2010	143
2011	182
2012	239
2013	265
2014	274
2015	318
2016	332
2017	363
2018	409
2019	475
2020	562
2021	657
2022	738
2023	761
2024	874
2025	858
2026	8

1

Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging.

Zhang Z, Ma B, Li B, Li Z, Gao M, Zhao H, Peng R, Hu J, Wang Y, You W, Gui X, Wang R, Hu X, Chen B, Zhang Y, Hao Y, Sun X, Rao P, Zhang L, Lu M, Zhou D, Yang Y, Deng M, Miao L. Zhang Z, et al. Among authors: ma b. Cell Rep Med. 2025 Jul 15;6(7):102209. doi: 10.1016/j.xcrm.2025.102209. Epub 2025 Jul 1. Cell Rep Med. 2025. PMID: 40602406 Free PMC article.

2

F-box/LRR-repeat protein 12 reorchestrated microglia to inhibit scarring and achieve adult spinal cord injury repair.

Xu X, Gao F, Chen Q, Chen B, Liang W, Huang R, Liu Y, Liu Z, Zhu Y, Lin G, Ma B, Yang L, Gao S, Zhu R, Cheng L. Xu X, et al. Among authors: ma b. Signal Transduct Target Ther. 2025 Aug 20;10(1):259. doi: 10.1038/s41392-025-02354-0. Signal Transduct Target Ther. 2025. PMID: 40830106 Free PMC article.

3

A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers.

Feng J, Xiao X, Xia X, Min J, Tang W, Shi X, Xu K, Zhou G, Li K, Shen P, Bao R, Wu S, Lin M, Yuan K, Lian Z, Hu L, Li N, Wu Z, Zhai X, Liu X, Hu K, Wu J, Ding C, Zhao H, Gong X, Zhang S, Jin J, Li D, Liu M, Ye Y, Ma B, Guo RT, Zhang A, Pang X. Feng J, et al. Among authors: ma b. Cancer Cell. 2025 Oct 13;43(10):1866-1884.e12. doi: 10.1016/j.ccell.2025.07.006. Epub 2025 Aug 7. Cancer Cell. 2025. PMID: 40780213 Free article.

4

A Peptide-Based PROTAC Degrader of BRCA2 Sensitizes Metastatic Castration-Resistant Prostate Cancer to PARP Inhibition.

Ye Q, Ma B, Li L, Wang Z, Lu M, Kang J, Lei Y, Xu S, Wang K, Jian Y, Fan Y, Wang B, Liu J, Gao Y, Ma J, Li L. Ye Q, et al. Among authors: ma b. Cancer Res. 2025 Sep 15;85(18):3490-3502. doi: 10.1158/0008-5472.CAN-24-4096. Cancer Res. 2025. PMID: 40729484

5

Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury.

Zhao Z, Shan X, Ding J, Ma B, Li B, Huang W, Yang Q, Fang Y, Chen J, Song C, Wei C, Liu S, Cheng X, Zhang S, Liu Y, Wu H, Luo C, Shu S, Qiao X, Wang Z, Lu X, Miao L. Zhao Z, et al. Among authors: ma b. Nat Commun. 2025 Jul 14;16(1):6477. doi: 10.1038/s41467-025-61688-z. Nat Commun. 2025. PMID: 40659631 Free PMC article.

6

Evolving landscape of nasopharyngeal carcinoma therapy.

Chin KW, Chong WQ, Goh BC, Ma BBY. Chin KW, et al. Among authors: ma bby. Nat Cancer. 2025 Sep;6(9):1480-1482. doi: 10.1038/s43018-025-01045-7. Nat Cancer. 2025. PMID: 40973778 No abstract available.

7

Integrating spatial omics and single-cell mass spectrometry imaging reveals tumor-host metabolic interplay in hepatocellular carcinoma.

Chen P, Geng H, Ma B, Zhang Y, Zhu Z, Li M, Chen S, Wang X, Sun C. Chen P, et al. Among authors: ma b. Proc Natl Acad Sci U S A. 2025 Aug 5;122(31):e2505789122. doi: 10.1073/pnas.2505789122. Epub 2025 Jul 29. Proc Natl Acad Sci U S A. 2025. PMID: 40729385

8

Epimedokoreanin B blocks autophagic flux to inhibit progression of triple negative breast cancer through targeting MCOLN1/TRPML1 channel.

Zhao C, Zhang P, Yang X, Liu M, Guan Z, Ma B, Duan X, Su C. Zhao C, et al. Among authors: ma b. Free Radic Biol Med. 2025 Dec 1;240:222-237. doi: 10.1016/j.freeradbiomed.2025.08.041. Epub 2025 Aug 20. Free Radic Biol Med. 2025. PMID: 40846097

9

Bioactivation and reactivity research advances-2024 year in review.

Liu J, Argikar UA, Brunetti P, Chatzopoulou M, Chen L, Cho S, Hauri S, Kramlinger V, Lang J, Ma B, Rehm K, Seneviratne HK, Tang LWT, Tran JC, Zhong G, Khojasteh SC. Liu J, et al. Among authors: ma b. Drug Metab Rev. 2025 Nov;57(4):362-399. doi: 10.1080/03602532.2025.2530407. Epub 2025 Jul 28. Drug Metab Rev. 2025. PMID: 40642940 Review.

10

Remodeling adipocytes' lipid metabolism with a polycation loaded enzyme-active framework reverses osteoporotic bone marrow.

Lin W, Gu S, Zhang X, Li K, Zhao D, Ma B, Pan C, Xu Z, Liu T, Wang H, Hu S, Chen H. Lin W, et al. Among authors: ma b. Nat Commun. 2025 Aug 27;16(1):8009. doi: 10.1038/s41467-025-63376-4. Nat Commun. 2025. PMID: 40866384 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,428 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,428 results

Results by year